Approximate counting and quantum computation by Bordewich, M, Freedman, M, Lovasz, L, Welsh, D

Topological quantum computing with only one mobile quasiparticle. by Simon, S, Bonesteel, N, Freedman, M, Petrovic, N, Hormozi, L

Non-Abelian anyons and topological quantum computation by Nayak, C, Simon, S, Stern, A, Freedman, M, Das Sarma, S

Large-scale transcriptome-wide association study identifies new prostate cancer risk regions by Mancuso, N, Gayther, S, Gusev, A, Zheng, W, Penney, K, Kote-Jarai, Z, Eeles, R, Freedman, M, Haiman, C, Pasaniuc, B, Practical Consortium

Precision prevention and early detection of cancer: Fundamental principles by Rebbeck, T, Burns-White, K, Chan, A, Emmons, K, Freedman, M, Hunter, D, Kraft, P, Laden, F, Mucci, L, Parmigiani, G, Schrag, D, Syngal, S, Tamimi, R, Viswanath, K, Yurgelun, M, Garber, J

A GENETIC-BASIS FOR FAMILIAL AGGREGATION IN MULTIPLE-SCLEROSIS by Ebers, G, Sadovnick, A, Risch, N, Bulman, D, Rice, G, Hashimoto, S, Paty, D, Oger, J, Metz, L, Bell, R, Warren, S, Hader, W, Auty, T, Nath, A, Gray, T, Oconnor, P, Nelson, R, Freedman, M, Brunet, D, Paulseth, R, Francis, G, Duquette, P, Murray, T, Bahn, V, Prysephillips, W

Evidence for genetic basis of multiple sclerosis by Sadovnick, A, Ebers, G, Dyment, D, Risch, N, Bulman, D, Rice, G, Hashimoto, SA, Paty, D, Oger, J, Metz, L, Bell, R, Warren, S, Hader, W, Auty, T, Nath, A, Gray, T, OConner, P, Nelson, R, Freedman, M, Brunet, D, Paulseth, R, Francis, G, Duquette, P, Murray, T, Bahn, V

INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL by Duquette, P, Despault, L, Knobler, R, Lublin, F, Kelley, L, Francis, G, Freedman, M, Lapierre, Y, Greenstein, J, Mishra, B, Delillio, N, Whitaker, J, Layton, B, Sibley, W, Laguna, J, Krikawa, J, Paty, D, Oger, J, Kastrukoff, L, Morrison, W, Nelson, J, Goodin, D, Massa, S, Gutteridge, E, Arnason, B

Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis. by Grisanzio, C, Werner, L, Takeda, D, Awoyemi, B, Pomerantz, M, Yamada, H, Sooriakumaran, P, Robinson, B, Leung, R, Schinzel, A, Mills, I, Ross-Adams, H, Neal, D, Kido, M, Yamamoto, T, Petrozziello, G, Stack, E, Lis, R, Kantoff, P, Loda, M, Sartor, O, Egawa, S, Tewari, A, Hahn, W, Freedman, M

A common 8q24 variant in prostate and breast cancer from a large nested case-control study. by Schumacher, F, Feigelson, H, Cox, D, Haiman, C, Albanes, D, Buring, J, Calle, E, Chanock, S, Colditz, G, Diver, W, Dunning, A, Freedman, M, Gaziano, J, Giovannucci, E, Hankinson, SE, Hayes, R, Henderson, B, Hoover, R, Kaaks, R, Key, T, Kolonel, L, Kraft, P, Le Marchand, L, Ma, J, Pike, M

“…When we exclude the Multiethnic Cohort samples, previously reported by Freedman et al., the association remains highly significant (P = 8.64 x 10(-13)). …”

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS by Francis, G, Hughes, R, King, J, Mitchell, P, Joubert, J, McLeod, J, Parker, G, Pollard, J, Sindic, C, Duprez, T, Medaer, R, Broeckx, J, Vanroose, E, Carton, H, Wilms, G, Rice, G, Ebers, G, Lee, D, Freedman, M, Nelson, R, Rabinovitch, H, Christie, S, Avruch, L, Oger, J, Paty, D

Genetic susceptibility to MS: a second stage analysis in Canadian MS families. by Dyment, D, Willer, C, Scott, B, Armstrong, H, Ligers, A, Hillert, J, Paty, D, Hashimoto, S, Devonshire, V, Hooge, J, Kastrukoff, L, Oger, J, Metz, L, Warren, S, Hader, W, Power, C, Auty, A, Nath, A, Nelson, R, Freedman, M, Brunet, D, Paulseth, J, Rice, G, O'Connor, P, Duquette, P

Longitudinal analyses of the effects of neutralizing antibodies on interferon beta-1b in relapsing-remitting multiple sclerosis by Petkau, A, White, R, Ebers, G, Reder, A, Sibley, W, Lublin, F, Paty, D, Duquette, P, Girard, M, Despault, L, DuBois, R, Knobler, R, Kelley, L, Francis, G, Lapierre, Y, Antel, J, Freedman, M, Hum, S, Greenstein, J, Mishra, B, Muldoon, J, Whitaker, J, Evans, B, Layton, B, Laguna, J

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. by Chen, Y, Kraft, P, Bretsky, P, Ketkar, S, Hunter, D, Albanes, D, Altshuler, D, Andriole, G, Berg, C, Boeing, H, Burtt, N, Bueno-de-Mesquita, B, Cann, H, Canzian, F, Chanock, S, Dunning, A, Feigelson, H, Freedman, M, Gaziano, J, Giovannucci, E, Sánchez, M, Haiman, C, Hallmans, G, Hayes, R, Henderson, B

Multiple regions within 8q24 independently affect risk for prostate cancer. by Haiman, C, Patterson, N, Freedman, M, Myers, S, Pike, M, Waliszewska, A, Neubauer, J, Tandon, A, Schirmer, C, McDonald, G, Greenway, S, Stram, DO, Le Marchand, L, Kolonel, L, Frasco, M, Wong, D, Pooler, L, Ardlie, K, Oakley-Girvan, I, Whittemore, A, Cooney, K, John, E, Ingles, SA, Altshuler, D, Henderson, B

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). by Cox, D, Blanché, H, Pearce, C, Calle, E, Colditz, G, Pike, M, Albanes, D, Allen, N, Amiano, P, Berglund, G, Boeing, H, Buring, J, Burtt, N, Canzian, F, Chanock, S, Clavel-Chapelon, F, Feigelson, H, Freedman, M, Haiman, C, Hankinson, SE, Henderson, B, Hoover, R, Hunter, D, Kaaks, R, Kolonel, L

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years by Duquette, P, Girard, M, Dubois, R, Kobler, R, Lublin, F, Kelley, L, Francis, G, Freedman, M, Greenstein, J, Mishra, B, DeLillio, N, Whitaker, J, Layton, B, Sibley, W, Laguna, J, Krikawa, J, Paty, D, Oger, J, Kastrukoff, L, Morrison, W, Nelson, J, Goodin, D, Massa, S, Gutteridge, E, Arnason, B

A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. by Schumacher, F, Cheng, I, Freedman, M, Mucci, L, Allen, N, Pollak, M, Hayes, R, Stram, DO, Canzian, F, Henderson, B, Hunter, D, Virtamo, J, Manjer, J, Gaziano, J, Kolonel, L, Tjønneland, A, Albanes, D, Calle, E, Giovannucci, E, Crawford, E, Haiman, C, Kraft, P, Willett, W, Thun, M, Le Marchand, L

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis by Ebers, G, Oger, J, Paty, D, Li, D, Freedman, M, Hartung, H, Hommes, O, McLeod, J, Sandberg, M, Wikstrom, J, Carton, H, Hughes, R, Pancelius, M, Medaer, R, Blumhardt, L, Barnes, D, Bertelsmann, F, Chofflon, M, Kappos, L, King, J, Newsom-Davis, J, Sindic, C, Uitehaag, B, Van Doom, P, Bates, D

Genetic variation in the HSD17B1 gene and risk of prostate cancer. by Kraft, P, Pharoah, P, Chanock, S, Albanes, D, Kolonel, L, Hayes, R, Altshuler, D, Andriole, G, Berg, C, Boeing, H, Burtt, N, Bueno-de-Mesquita, B, Calle, E, Cann, H, Canzian, F, Chen, Y, Crawford, D, Dunning, A, Feigelson, H, Freedman, M, Gaziano, J, Giovannucci, E, Gonzalez, C, Haiman, C, Hallmans, G, Henderson, B, Hirschhorn, J, Hunter, D, Kaaks, R, Key, T, Le Marchand, L, Ma, J, Overvad, K, Palli, D, Pike, M, Riboli, E, Rodriguez, C, Setiawan, W, Stampfer, M, Stram, DO, Thomas, G, Thun, M, Travis, R, Trichopoulou, A, Virtamo, J, Wacholder, S